Diwa, Khalif M.
HRN: 27-84-75 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
CEFTRIAXONE 1G (VIAL)
12/30/2025
12/30/2025
IV DRIP
300mg
Q12
PCAP-C With Moderate Dehydration
Checking Initial Appropriateness
12/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/30/2025
01/06/2026
IV DRIP
480mg
Q8
PCAP-C With Moderate Dehydration
Checking Initial Appropriateness
01/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/01/2026
01/08/2026
IV
90 Mg
Q24hrs
Pcap C
Checking Final Appropriateness